Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011570 (depression)
 172,036 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We studied the psychological and emotional problems experienced by seven children and their families who underwent bone marrow transplantation at the University of Colorado Medical Center from 1973 to 1975. These problems included (1) anxiety and depression relating to isolation, fear of death, and painful procedures; (2) an overdependence associated with a feeling of helplessness; (3) anger directed toward both the staff and the parents; (4) a reduced tolerance for medical procedures; and (5) periodic refusal to cooperate. Initially we had been concerned that patients might become agitated, psychotic, or even suicidal. These did not occur. Severe anxiety over bodily changes was not a problem. We did not encounter prolonged refusal to cooperate, refusal to remain in isolation, or drug addiction. Important aspects in management included an honest, straightforward, and direct discussion of all aspects of transplantation, including the potential complications and the risks of death from the underlying disease or from complications of transplantation. A firm but understanding approach to the patients appeared to be the most effective method to develop their continuing cooperation. The opportunity for patients to express verbally their fears of procedures and of death was essential. The donors needed help in working through their feelings of guilt if a transplant was not successful. The parents needed continuing psychological support for the many personal, social, and psychological difficulties which they had to face.
 ...
PMID:Psychological issues in bone marrow transplantation. 40 Jul 8

Depressive diseases are among the most frequent illnesses. They are only partly recognized and treated. The largest number of depressed patients are found in the offices of the general practitioner and internist. Only a small fraction of patients with severe, predominantly endogenous psychotic depressions are treated in hospital. The following consequences arise from this frequency distribution: by improvement of diagnostic methods to recognize, if at all possible, all depressed patients requiring therapy and to treat them suitably; by improvement of prevention, primary in risk groups and tertiary in prophylaxis of recurrence, to lower the morbidity of depression; and by improvement of ambulant therapy with regard to controlling suicidal tendencies and anxiety and prevention of chronicity and resistance to therapy to reduce the necessity for hospitalization.
 ...
PMID:[Frequency of depressive diseases (author's transl)]. 40 62

In a study of electrolytes in lumbar cerebrospinal fluid (csf) from psychiatric patients, the authors found a positive correlation between calcium concentration and symptom severity in hospitalized depressed patients. CSF calcium levels tended to decrease as patients improved. In four rapidly cycling patients, CSF calcium was higher during depression than during mania. Mean CSF calcium for the depressed patients as a group was not significantly different from neurological controls or other psychiatric patients. Symptom remission from acute psychosis in schizophrenic patients was accompanied by a significant increase in CSF calcium concentration. These findings are discussed in relationship to calcium-induced alterations in neuronal and physiological excitability.
 ...
PMID:CSF calcium: clinical correlates in affective illness and schizophrenia. 42 Sep 7

SAdness and normal grief are distinguished from pathological grief and depression by intensity, duration, precipitating events, and the quality of psychopathological features. Depression is evaluated as a final common pathway of potential psychodynamic, genetic, psychosocial, physiological, and personality characteristics or events. The clinical entity of depression is diagnosed by describing some of each of the affective, behavioral, and cognitive changes concomitant with depression. The clinical entity of depression is further differentiated for purposes of treatment into the categories of bipolar depression (manic-depressive illness), unipolar depression (psychotic depressive reaction or involutional melancholia), neurotic depression, and secondary depression (secondary to somatic disease, drugs, or to other psychiatric disorders). The immediate treatment depends on the type of depression diagnosed. Unipolar and bipolar depressions respond to specific pharmacologic therapy and supportive care. Neurotic and characterologic depressions respond to supportive or insight psychotherapy with possible brief adjunctive anti-anxiety or hypnotic medication. All of the treatment modalities, with the possilbe exception of insight psychotherapy, can be effected very adequately by the primary care physician who is given clear diagnostic and assessment guidelines with specific treatment approaches.
 ...
PMID:The depressed patient. 42 80

A psychiatric field-survey was conducted in three villages in West Bengal, India in order to correlate the prevalence of mental morbidity with the socio-economic status of the families. The sample was divided into four groups on the basis of religion or caste. Total morbidity had no statistically significant relationship with socio-economic status in any of the four groups. In the total sample it was directly related. Higher classes had significantly higher rates. Psychoses were not correlated with socio-economic status in any of the groups. Neuroses showed a significantly higher rate in the upper strata of two groups; in the other two groups the trend of prevalence was in the same direction. The four groups had significant differences in their rates of total morbidity. In all the groups females had a higher rate of mental morbidity. Psychoses, Neuroses and Depression were commoner in females and Schizophrenia was commoner in males.
 ...
PMID:Socio-economic status and prevalence of mental disorders in certain rural communities in India. 43 27

This study suggests that patients receiving daily doses of 40 mg of prednisone or its equivalent, are at greater risk for developing steroid psychosis. Psychotic reactions were twice as likely to occur during the first 5 days of treatment as subsequently. Premorbid personality, history of previous psychiatric disorder, and a history of previous steroid psychosis did not clearly increase the patient's risk of developing psychotic reaction during any given course of therapy. Steroid psychoses present as spectrum psychoses with symptoms ranging from affective through schizophreniform to those of an organic brain syndrome. No characteristic stable presentation was observed in these 14 cases reported here. The most prominent symptom constellation to appear some time during the course of the illness consisted of emotional lability, anxiety, distractibility, pressured speech, sensory flooding, insomnia, depression, perplexity, agitation, auditory and visual hallucinations, intermittent memory impairment, mutism, disturbances of body image, delusions, apathy, and hypomania. Phenothiazines administered in average daily doses of 212 mg produced excellent response in all patients studied. Of particular note was the fact that tricyclic antidepressants produced an exacerbation or worsening of the clinical state in all patients to whom they were administered.
 ...
PMID:Presentation of the steroid psychoses. 43 94

The authors studied the catecholamine metabolism with an additional use of the function loadings by insulin and adrenalin in 77 epileptic patients who were ill for a long time and had marked disturbances in mental activity. The study was conducted in dynamics. The authors revealed a considerable activation of catecholamine metabolism in patients with acute psychotic states during dysphoria and in periods close to attacks against the background of typical, for the studied group, depression of the sympathoadrenalin system. The differences in the nature of reaction to the functional loadings, changing in various stages of the disease development and reflecting, to some extent, the compensatory possibilities of organism were registered.
 ...
PMID:[Catecholamine metabolism in various compensatory manifestations of epilepsy patients]. 44 1

A total of 218 patients from 19-40 years of age with different depressions were examined. Four types of depressive disorders were distinguished: neurotic, hypopsychotic, psychotic, depressive-paranoid. It was demonstrated that depressive conditions of various severity possess differential symptoms with significantly different probabilities. Each clinical group had a certain set of differential symptoms, the amount and syndromal-diagnostical value of which was in a direct correlation with the affect severity. Signs of depression got complicated only to a certain limit. In depressive-paranoid syndrome there was a splitting of the depressive symptomatology: enhancement of some symptoms and alleviation of others.
 ...
PMID:[Severity of depression (clinico-statistical study)]. 44 15

Nomifensine is a tetrahydoisoquinoline antidepressant which is chemically unrelated to the tricyclic or tetracyclic antidepressants, the monoamine oxidase inhibitors or the recently introduced agents. Nomifensine resembles the tricyclic antidepressants in many of its pharmacological effects in animal models of depressive illness, but differs from them in that it strongly inhibits the re-uptake of dopamine as well as noradrenaline and is a relatively weak inhibitor of serotonin uptake. It has an overall efficacy comparable with that of imipramine and amitriptyline in depressive illness, but at dosages which have achieved a similar overall clinical improvement, nomifensine causes little or no sedation, fewer and milder anticholinergic side effects, and also appears less likely than these drugs to cause serious cardiotoxicity on overdosage. Nomifensine may aggravate the psychopathology of patients with schizo-affective disorders and intensification of the psychosis may require neuroleptic therapy. Nomifensine also has antianxiety activity, but its role in treating anxiety associated with primary depression has still to be clarified. Nomifensine appears to be well tolerated by the elderly.
 ...
PMID:Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. 47 72

Patients treated by maintenance hemodialysis are subjected to many stresses. As a result, many of these patients have psychological problems. Depression is the most common psychological complication seen in them. This is reflected in a high suicide rate in these patients. Other psychological problems seen in these patients are anxiety, sexual dysfunctions, problems connected with difficulties in rehabilitation, the problem of the 'uncooperative' patients, and psychosis. Vigilant attention is required so that diagnosis may be made early and treatment started soon thereafter. Important methods of treatment are supportive psychotherapy, behavioral techniques for sexual dysfunctions, and the use of psychologically active drugs.
 ...
PMID:Psychological problems of the patient on hemodialysis and their treatment. 48 48


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>